The effect of reduction in cross-validation intervals on the performance of multifactor dimensionality reduction.

Abstract excerpt

Multifactor Dimensionality Reduction (MDR) was developed to detect genetic polymorphisms that present an increased risk of disease. Cross-validation (CV) is an important part of the MDR algorithm, as it prevents over-fitting and allows the predictive ability of a model to be evaluated. CV is a computationally intensive step in the MDR algorithm. Traditionally, MDR has been implemented using 10-fold CV. In order...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Alzheimer Disease
• Share to Genetic Predisposition to Disease